Merken Biotech

At Merken Biotech, we bring together creative minds, state-of-the-art infrastructure, and a top-tier team to conduct high-quality science. With over 15 years of experience, we transform ideas into impactful products, advancing scientific research in biomedicine, pharmacology and biotechnology. Our expert lab specializes in molecular biology, cell biology, pharmacology, and bioprocessing, helping partners efficiently develop biotech products and innovative therapies for human diseases. Our team’s involvement in the development of Xtandi, acquired by Pfizer and marketed by the pharmaceutical companies Astellas-Pfizer, showcases our dedication and expertise in the field. We support companies through patenting and licensing processes, enabling them to make meaningful scientific advancements.